Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Should You Buy Vaxart Stock?

TheMotleyFool

0 0

Should You Buy Vaxart Stock?Photo, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Vaxart (NASDAQ: VXRT) isn't as well-known as other coronavirus vaccine makers. However, the small biotech stock emerged as a huge winner in 2020. Vaxart is currently evaluating its tablet COVID-19 vaccine in an early stage clinical study. In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights answer a viewer's question about whether or not investors should buy Vaxart stock now.

Source Fool.com

Like: 0

VXRT

Teilen